MEGHAN CUNNINGHAM: Open Payments
NPI 1487418109 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,945 in 71 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,200 · 2025 $1,945
Food & beverage: $1,945
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $827 |
| Ardelyx, Inc. | 10 | $371 |
| PFIZER INC. | 7 | $219 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $104 |
| Lilly USA, LLC | 5 | $92 |
| Aimmune Therapeutics, Inc. | 4 | $63 |
| Phathom Pharmaceuticals, Inc. | 4 | $33 |
| GENZYME CORPORATION | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $21 |
Products named: IBSRELA, RINVOQ, LINZESS, SKYRIZI, VELSIPITY, XIFAXAN, OMVOH, ENTYVIO.
Industry payments across FL — which companies pay providers there.
